These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 5350617)
21. [On results of the bacterological examination of preserved blood, plasma and erythrocytes in a central regional blood donor service (1958-1961)]. BROCKELMANN C; UNGAR W; HAUSSMANN HG Bibl Haematol; 1963; 16():238-42. PubMed ID: 14015628 [No Abstract] [Full Text] [Related]
23. [Preparation of blood from donors in a specialized surgical institution]. Guseinov ChS; Privalova LI; Fedorova NM; Perova SA; Remizova TA Khirurgiia (Mosk); 1971 Sep; 47(9):114-6. PubMed ID: 5150225 [No Abstract] [Full Text] [Related]
24. [Improved blood preservation by addition of adenine and guanosine]. Roigas H; Strauss D; Raderecht HJ; Höckendorff I Z Gesamte Inn Med; 1969 Dec; 24(23):850-6. PubMed ID: 5364864 [No Abstract] [Full Text] [Related]
26. Optimal use of blood components and derivatives. Walter WJ; Oberman HA Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570 [No Abstract] [Full Text] [Related]
28. Threefold increase in demand for blood concentrates. J Ir Med Assoc; 1973 Apr; 66(8):225. PubMed ID: 4698654 [No Abstract] [Full Text] [Related]
29. [Correction of metabolic shifts in preserved donor blood by using the "artificial kidney" apparatus]. Klepikov FA; Arkatov VA; Tomakh IuF; Semchenko IuP; Chirva LF Voen Med Zh; 1973 Dec; 12():24-6. PubMed ID: 4785665 [No Abstract] [Full Text] [Related]
30. [The organization of the donation of autologous blood and its components in cardiac surgery]. Shevchenko IuL; Matveev SA; Danil'chenko VV; Chechetkin AV; Khubulava GG; Shilov VV; Lapidus AV Vestn Khir Im I I Grek; 1996; 155(5):71-4. PubMed ID: 9123764 [TBL] [Abstract][Full Text] [Related]
32. [Prevention of transmission of infectious hepatitis by blood preparations through screening of GOT in blood donors]. Novák J; Urbánková J Cas Lek Cesk; 1969 Jun; 108(24):734-7. PubMed ID: 5783179 [No Abstract] [Full Text] [Related]
33. Which are the parameters to be controlled in platelet concentrates in order that they may be offered to the medical profession as a standardized product with specific properties? Vox Sang; 1981 Feb; 40(2):115-26. PubMed ID: 7233883 [No Abstract] [Full Text] [Related]
34. [Blood groups and blood banks]. Nappi R Arcisp S Anna Ferrara; 1970; 23(4):253-60. PubMed ID: 5523485 [No Abstract] [Full Text] [Related]
35. [Blood management in surgery--an analysis]. Erhard J; Schlensak M; Friedrich J Zentralbl Chir; 2003 Jun; 128(6):481-6. PubMed ID: 12865953 [TBL] [Abstract][Full Text] [Related]
36. [Survival of toxoplasma in preserved donor blood and its components]. Shkarin VV Med Parazitol (Mosk); 1968; 37(4):433-5. PubMed ID: 5732626 [No Abstract] [Full Text] [Related]
37. Decreasing the risk of allogenic blood in the 21st century. Popovsky MA; O'Neill EM; Cannon M Med Health R I; 1998 Dec; 81(12):392-5. PubMed ID: 9884538 [No Abstract] [Full Text] [Related]
38. Methods to minimize transfusion related bacterial sepsis. Brecher ME Dev Biol (Basel); 2002; 108():69-84. PubMed ID: 12220144 [No Abstract] [Full Text] [Related]